NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Investigators at University College, University College of Dublin zero in on breast cancer



February 1st, 2007

A report, "Growth factor-dependent regulation of survivin by c-myc in human breast cancer," is newly published data in Journal of Molecular Endocrinology. "Survivin has emerged as a unique regulator of cell death through its response to growth factors, such as basic fibroblast growth factor (bFGF), which we have previously shown to be mitogen-activated protein kinase (MAPK) dependent. The transcriptional complex myc/max is an oncogene that lies downstream of the MAPK pathway, suggesting a possible role in survivin's regulation," scientists writing in the Journal of Molecular Endocrinology report.

"In this study, we investigated the ability of bFGF to induce...


Source: Women's Health Weekly (2007-02-01)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login